http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102229634-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab8272d8dee739b574c817ca9d0e13bb |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate | 2011-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c85e2eab28cbba126275e4cab4f1a9ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fcee68a757dfed3042ecd0ba9067023 |
| publicationDate | 2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102229634-B |
| titleOfInvention | Levo-isovaleryl spiramycin I and preparation, preparation method and application thereof |
| abstract | The invention relates to levo-isovaleryl spiramycin I and a preparation, a preparation method and application thereof. The preparation consists of the levo-isovaleryl spiramycin I and pharmaceutically acceptable carriers and/or excipient, wherein the purity of the levo-isovaleryl spiramycin I is over 90 weight percent, preferably over 95 weight percent and further preferably over 98 weight percent. The levo-isovaleryl spiramycin I has good antimicrobial activity; the preparation of the levo-isovaleryl spiramycin I comprises water injection, powder injection or freeze dried powder injection; the preparation fills the blank of the single component preparation of the isovaleryl spiramycin I at present market, and provides a new path with quick response for treating anti-infective diseases; and the production process for the preparation of single component of the isovaleryl spiramycin I is stable, standard and easily controlled in quality and suitable for large-scale industrialized production. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3782627-A4 |
| priorityDate | 2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.